High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma

Andrea Ambrosini-Spaltro, Fabrizio Salvi, Rossella Miglio, Luciano Liguori, Carlo Fabbri, Antonio Piemontese, Ombretta Martelli, Giovanni P. Frezza, Maria P. Foschini

Research output: Contribution to journalArticle

Abstract

The purpose of this study is to establish if mucoid differentiation is associated with responsiveness to preoperative radiochemotherapy (RCT) in rectal adenocarcinomas. Thirty-two patients with rectal adenocarcinomas were preoperatively treated with 44 to 46 Gy in 22 to 23 fractions and with 5-fluorouracil (200 to 225 mg/m) before surgery. Mucoid differentiation was searched for both in pre-RCT biopsies with anti-MUC2 antiserum and in postoperative specimens. To evaluate the responsiveness to preoperative RCT, a regression grading was used (grades 0 to 4). Statistical analysis showed a significant negative correlation between immunohistochemical expression of MUC2 in pre-RCT biopsies and regression grade in postoperative specimens (r=-0.529; P=0.002). A significant cutoff value of 60% of MUC2 positive neoplastic cells in pre-RCT biopsies was observed (P=0.018): 13 cases with more than 60% exhibited a poor response to RCT (grade 0 in 5/13, grade 1 in 4/13, grade 2 in 4/13), whereas 19 cases with less than 60% showed a better response to RCT (grade 1 in 6/19, grade 2 in 9/19, grade 3 in 3/19, grade 4 in 1/19).

Original languageEnglish
Pages (from-to)227-231
Number of pages5
JournalApplied Immunohistochemistry and Molecular Morphology
Volume16
Issue number3
DOIs
Publication statusPublished - May 2008

Fingerprint

Chemoradiotherapy
Adenocarcinoma
Biopsy
Fluorouracil
Immune Sera

Keywords

  • Adenocarcinoma
  • Chemotherapy
  • MUC2
  • Mucoid
  • Radiotherapy
  • Rectum

ASJC Scopus subject areas

  • Anatomy
  • Medical Laboratory Technology

Cite this

High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma. / Ambrosini-Spaltro, Andrea; Salvi, Fabrizio; Miglio, Rossella; Liguori, Luciano; Fabbri, Carlo; Piemontese, Antonio; Martelli, Ombretta; Frezza, Giovanni P.; Foschini, Maria P.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 16, No. 3, 05.2008, p. 227-231.

Research output: Contribution to journalArticle

Ambrosini-Spaltro, Andrea ; Salvi, Fabrizio ; Miglio, Rossella ; Liguori, Luciano ; Fabbri, Carlo ; Piemontese, Antonio ; Martelli, Ombretta ; Frezza, Giovanni P. ; Foschini, Maria P. / High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma. In: Applied Immunohistochemistry and Molecular Morphology. 2008 ; Vol. 16, No. 3. pp. 227-231.
@article{f9a6c8699c29488bb49ffd29a0ae8da8,
title = "High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma",
abstract = "The purpose of this study is to establish if mucoid differentiation is associated with responsiveness to preoperative radiochemotherapy (RCT) in rectal adenocarcinomas. Thirty-two patients with rectal adenocarcinomas were preoperatively treated with 44 to 46 Gy in 22 to 23 fractions and with 5-fluorouracil (200 to 225 mg/m) before surgery. Mucoid differentiation was searched for both in pre-RCT biopsies with anti-MUC2 antiserum and in postoperative specimens. To evaluate the responsiveness to preoperative RCT, a regression grading was used (grades 0 to 4). Statistical analysis showed a significant negative correlation between immunohistochemical expression of MUC2 in pre-RCT biopsies and regression grade in postoperative specimens (r=-0.529; P=0.002). A significant cutoff value of 60{\%} of MUC2 positive neoplastic cells in pre-RCT biopsies was observed (P=0.018): 13 cases with more than 60{\%} exhibited a poor response to RCT (grade 0 in 5/13, grade 1 in 4/13, grade 2 in 4/13), whereas 19 cases with less than 60{\%} showed a better response to RCT (grade 1 in 6/19, grade 2 in 9/19, grade 3 in 3/19, grade 4 in 1/19).",
keywords = "Adenocarcinoma, Chemotherapy, MUC2, Mucoid, Radiotherapy, Rectum",
author = "Andrea Ambrosini-Spaltro and Fabrizio Salvi and Rossella Miglio and Luciano Liguori and Carlo Fabbri and Antonio Piemontese and Ombretta Martelli and Frezza, {Giovanni P.} and Foschini, {Maria P.}",
year = "2008",
month = "5",
doi = "10.1097/PAI.0b013e3181545944",
language = "English",
volume = "16",
pages = "227--231",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma

AU - Ambrosini-Spaltro, Andrea

AU - Salvi, Fabrizio

AU - Miglio, Rossella

AU - Liguori, Luciano

AU - Fabbri, Carlo

AU - Piemontese, Antonio

AU - Martelli, Ombretta

AU - Frezza, Giovanni P.

AU - Foschini, Maria P.

PY - 2008/5

Y1 - 2008/5

N2 - The purpose of this study is to establish if mucoid differentiation is associated with responsiveness to preoperative radiochemotherapy (RCT) in rectal adenocarcinomas. Thirty-two patients with rectal adenocarcinomas were preoperatively treated with 44 to 46 Gy in 22 to 23 fractions and with 5-fluorouracil (200 to 225 mg/m) before surgery. Mucoid differentiation was searched for both in pre-RCT biopsies with anti-MUC2 antiserum and in postoperative specimens. To evaluate the responsiveness to preoperative RCT, a regression grading was used (grades 0 to 4). Statistical analysis showed a significant negative correlation between immunohistochemical expression of MUC2 in pre-RCT biopsies and regression grade in postoperative specimens (r=-0.529; P=0.002). A significant cutoff value of 60% of MUC2 positive neoplastic cells in pre-RCT biopsies was observed (P=0.018): 13 cases with more than 60% exhibited a poor response to RCT (grade 0 in 5/13, grade 1 in 4/13, grade 2 in 4/13), whereas 19 cases with less than 60% showed a better response to RCT (grade 1 in 6/19, grade 2 in 9/19, grade 3 in 3/19, grade 4 in 1/19).

AB - The purpose of this study is to establish if mucoid differentiation is associated with responsiveness to preoperative radiochemotherapy (RCT) in rectal adenocarcinomas. Thirty-two patients with rectal adenocarcinomas were preoperatively treated with 44 to 46 Gy in 22 to 23 fractions and with 5-fluorouracil (200 to 225 mg/m) before surgery. Mucoid differentiation was searched for both in pre-RCT biopsies with anti-MUC2 antiserum and in postoperative specimens. To evaluate the responsiveness to preoperative RCT, a regression grading was used (grades 0 to 4). Statistical analysis showed a significant negative correlation between immunohistochemical expression of MUC2 in pre-RCT biopsies and regression grade in postoperative specimens (r=-0.529; P=0.002). A significant cutoff value of 60% of MUC2 positive neoplastic cells in pre-RCT biopsies was observed (P=0.018): 13 cases with more than 60% exhibited a poor response to RCT (grade 0 in 5/13, grade 1 in 4/13, grade 2 in 4/13), whereas 19 cases with less than 60% showed a better response to RCT (grade 1 in 6/19, grade 2 in 9/19, grade 3 in 3/19, grade 4 in 1/19).

KW - Adenocarcinoma

KW - Chemotherapy

KW - MUC2

KW - Mucoid

KW - Radiotherapy

KW - Rectum

UR - http://www.scopus.com/inward/record.url?scp=42549149701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549149701&partnerID=8YFLogxK

U2 - 10.1097/PAI.0b013e3181545944

DO - 10.1097/PAI.0b013e3181545944

M3 - Article

VL - 16

SP - 227

EP - 231

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 3

ER -